Your session is about to expire
← Back to Search
Continuous Glucose Monitor
Continuous Glucose Monitoring Initiation at Hospital Discharge (CGM4Home Trial)
N/A
Waitlist Available
Led By Paulina Cruz Bravo, MD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 month and 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the use of a continuous glucose monitor (CGM) called FreeStyle Libre 2 for patients with poorly controlled diabetes. The device is attached to the arm and continuously measures blood sugar levels. The goal is to see if using this device helps improve blood sugar control and quality of life.
Eligible Conditions
- Diabetes
- Hypoglycemia Anxiety Disorder
- Low Blood Sugar
- Low blood sugar awareness
- High Blood Sugar
- Type 1 Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 1 month and 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 month and 3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
To Determine the Feasibility of Initiating a Continuous Glucose Monitoring in Patients With Diabetes at Hospital Discharge
Secondary study objectives
Mean Change in Self-efficacy at 3 Months
Mean Time in Range Outcomes
Percentage of Patients That Discontinue the CGM
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CGM InterventionExperimental Treatment1 Intervention
All eligible patients will receive a Continuous Glucose Monitor (CGM) prior to hospital discharge after signing an informed consent.
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,997 Previous Clinical Trials
2,298,741 Total Patients Enrolled
16 Trials studying Diabetes
5,242 Patients Enrolled for Diabetes
Paulina Cruz Bravo, MDPrincipal Investigator - Washington University School of Medicine
Washington University School of Medicine